Dr. Michael V. Boland, MD

Dr. Boland practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Boland's NPI, 1023074143, was assigned on April 26, 2006. Dr. Boland graduated from University of Pittsburgh School of Medicine in 2001. Dr. Boland holds Massachusetts license 284217.

Dr. Boland's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Boland's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Boland is also affiliated with Massachusetts Eye and Ear. Dmand AI also links Dr. Boland to 1 more community health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boland practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Boland's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Boland is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Boland's licenses on file in 4 states: Massachusetts, Maryland, Iowa and Pennsylvania.

Dmand AI lists cataract, cataract surgery with lens implant, conjunctivitis, dry eye, glaucoma, glaucoma surgery and secondary membranaous cataract surgery among the conditions Dr. Boland treats.

CMS data shows 2,062 Medicare services from Dr. Boland across 12 procedure codes in 2024, for 545 Medicare patients. Medicare paid $131,258 for them.

CMS counts 545 Medicare patients who saw Dr. Boland in 2024. The largest group is 75 to 84, with 243 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Boland's median patient age at 74, with 52% women.

In 2024, Dr. Boland wrote 1,688 Medicare Part D claims for 412 patients. 76% of them were for generic drugs. CMS names the drug for 1,589 of them, across 14 drugs with 11 or more claims each, at $56,353 in total drug cost. In 2023, CMS named 1,334 claims across 9 drugs.

Dr. Boland accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 80 procedures of cataract surgery by Dr. Boland, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 138 papers to Dr. Boland, published from 2008 to 2025. 2022 was the busiest year, with 16. The most frequent topics are Glaucoma, Visual Fields and Visual Field Tests. Dr. Boland has published most often in Ophthalmology. Dr. Boland's most frequent co-authors are David S. Friedman, MD, Louis Robert Pasquale, MD and Lucy Qing Shen, MD.

Dmand AI links Dr. Boland to 2 clinical trials. Conditions studied include Glaucoma, Glaucoma, Open-Angle and Ocular Hypertension.

CMS Open Payments shows 49 general payments to Dr. Boland from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 84% of the total. Topcon Medical Systems, Inc. paid the most, $34,106.

Dmand AI lists 2 awards for Dr. Boland, most recently CMS Stage 1 EHR in 2014.

Dr. Boland graduated from University of Pittsburgh School of Medicine in 2001. Dr. Boland is a member of AAO, American Glaucoma Society and Association for Research in Vision and Ophthalmology.

Dr. Boland is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.